$COPR
Idaho Copper Corp

2022 Q1 Form 10-Q Financial Statement

#000121390022025771 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.33K $83.43K
YoY Change -87.62% -75.66%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.33K $83.43K
YoY Change -87.62% -75.66%
Operating Profit -$10.33K -$83.43K
YoY Change -87.62% -75.21%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$10.33K -$83.43K
YoY Change -87.62% -75.27%
Income Tax
% Of Pretax Income
Net Earnings -$10.33K -$83.43K
YoY Change -87.62% -75.27%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$515.10 -$4.160K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $0.00 $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $113.4K $828.3K
YoY Change -86.31% -54.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $113.4K $828.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $113.4K $828.3K
YoY Change -86.31% -54.2%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$113.4K -$828.3K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change -100.0%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$10.33K -$83.43K
YoY Change -87.62% -75.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 -$7.240K
YoY Change -100.0% -94.9%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 7.240K
YoY Change -100.0% -91.68%
NET CHANGE
Cash From Operating Activities 0.000 -7.240K
Cash From Investing Activities
Cash From Financing Activities 0.000 7.240K
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 -$7.240K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
USD
CY2021Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
USD
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001263364
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
USD

Files In Submission

Name View Source Status
0001213900-22-025771-index-headers.html Edgar Link pending
0001213900-22-025771-index.html Edgar Link pending
0001213900-22-025771.txt Edgar Link pending
0001213900-22-025771-xbrl.zip Edgar Link pending
f10q0322ex31-1_jowayhealth.htm Edgar Link pending
f10q0322ex32-1_jowayhealth.htm Edgar Link pending
f10q0322_jowayhealth.htm Edgar Link pending
f10q0322_jowayhealth_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gtvi-20220331.xsd Edgar Link pending
gtvi-20220331_cal.xml Edgar Link unprocessable
gtvi-20220331_def.xml Edgar Link unprocessable
gtvi-20220331_lab.xml Edgar Link unprocessable
gtvi-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending